Uroš Rot

Assays of different aspects of haemostasis – what do they measure?

Myasthenia Gravis

A Potential Role for B-Cell Activating Factor in the Pathogenesis of Autoimmune Myasthenia Gravis

The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes

Mechanisms Underlying Inflammation in Neurodegeneration

Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation

Pharmacology and therapeutic potential of interferons

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

Updated Clinical Classification of Pulmonary Hypertension

Myasthenia gravis

Sildenafil Therapy for Interferon-β-1a-Induced Pulmonary Arterial Hypertension: A Case Report

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

The Overall Hemostasis Potential: A Laboratory Tool for the Investigation of Global Hemostasis

B cells as therapeutic targets in autoimmune neurological disorders

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

Inflammatory bone loss: pathogenesis and therapeutic intervention

Myasthenia gravis: subgroup classification and therapeutic strategies

Epstein‐Barr virus persistence and reactivation in myasthenia gravis thymus

Atacicept: targeting B cells in multiple sclerosis

Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.

Challenging the current model of early‐onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens

The thymus is a source of B-cell-survival factors–APRIL and BAFF–in myasthenia gravis

Increased levels of APRIL (A Proliferation-Inducing Ligand) mRNA in multiple sclerosis

Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis

Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis

Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia

Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report